SCHEMBL3836337

SCHEMBL3836337

CC(C)Oc1c(OC(N)=O)[nH]c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 3/20 0.41
GSK3B P49841 2/20 0.41
ADK P55263 2/20 0.41
HSD17B10 Q99714 2/20 0.41
KMT2A Q03164 3/20 0.40
USP2 O75604 1/20 0.40
ALOX12 P18054 1/20 0.40
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 2/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3839795 0.84 KDM4E (0.53) KDM4EALDH1A1HPGDGSK3BADK
SCHEMBL3837499 0.80 HTR6 (0.41) KDM4EALDH1A1HPGDGSK3BADK
SCHEMBL3838681 0.80 KIF11 (0.42) KDM4EALDH1A1HPGDGSK3BADK
SCHEMBL2351116 0.79 MAP2 (0.51) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL3839787 0.78 SCN9A (0.43) KDM4EALDH1A1HPGDGSK3BADK
SCHEMBL3839803 0.77 TUBB4A (0.44) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL3835352 0.75 HSD17B10 (0.48) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL7594375 0.75 KDM4E (0.51) KDM4EALDH1A1HPGDHSD17B10KMT2A
SCHEMBL3839281 0.74 KDM4E (0.39) KDM4EALDH1A1HPGDGSK3BADK
SCHEMBL3834645 0.74 ALDH1A1 (0.43) KDM4EALDH1A1HPGDGSK3BADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1791537-B1 3-ARYLTHIOINDOLE-2-CARBOXAMIDE DERIVATIVES AND ANALOGS THEREOF AS INHIBITORS OF CASEIN KINASE I AVENTIS PHARMA INC (US) 2009-10-14 EP claimed